Skip to content

Application of traction method in endoscopic submucosal dissection for early gastric cancer

Application of traction method in endoscopic submucosal dissection for early gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085613
Enrollment
Unknown
Registered
2024-06-13
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

Sponsors

The Second Hospital & Clinical Medical School,Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients, aged 18–90 years, with early gastric tumors(EGTs) of 20–50 mm in diameter, located in the upper/middle part of stomach(except fornix), diagnosed by magnifying endoscopic findings with equipment-based image-enhanced endoscopy (IEE), and/or diagnosed through pathological biopsy ,considered difficult to achieve en bloc resection by inexperienced endoscopist,were screened for inclusion into the study.

Exclusion criteria

Exclusion criteria: 1.Severe anemia, coagulation dysfunction, heart, lung, liver and kidney dysfunction, severe acute infection, pregnant patients 2.Inability to tolerate intravenous anesthesia cases; 3.Patients who cannot accept surgical partial or total gastrectomy as an alternative option; 4.an EGC predicted to be deep submucosal invasion cancer using Endoscopic ultrasound examination; 5.local recurrence after endoscopic resection; 6.an inability to discontinue antithrombotic agents and anticoagulants (except for low-dose aspirin); 7.The other patients who are not expected to benefit from ESD surgery.

Design outcomes

Primary

MeasureTime frame
Dissection speed;

Secondary

MeasureTime frame
Number of intraoperative hemostasis;Intraoperative perforation;Myometrium injury;Dissection duration;The total amount of fluid injected under the mucosa;

Countries

China

Contacts

Public ContactWANG PENGFEI

The Second Hospital & Clinical Medical School, Lanzhou University

wpfw@foxmail.com+86 181 5367 3602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026